Literature DB >> 20862662

Cure fraction model with random effects for regional variation in cancer survival.

Karri Seppä1, Timo Hakulinen, Hyon-Jung Kim, Esa Läärä.   

Abstract

Assessing regional differences in the survival of cancer patients is important but difficult when separate regions are small or sparsely populated. In this paper, we apply a mixture cure fraction model with random effects to cause-specific survival data of female breast cancer patients collected by the population-based Finnish Cancer Registry. Two sets of random effects were used to capture the regional variation in the cure fraction and in the survival of the non-cured patients, respectively. This hierarchical model was implemented in a Bayesian framework using a Metropolis-within-Gibbs algorithm. To avoid poor mixing of the Markov chain, when the variance of either set of random effects was close to zero, posterior simulations were based on a parameter-expanded model with tailor-made proposal distributions in Metropolis steps. The random effects allowed the fitting of the cure fraction model to the sparse regional data and the estimation of the regional variation in 10-year cause-specific breast cancer survival with a parsimonious number of parameters. Before 1986, the capital of Finland clearly stood out from the rest, but since then all the 21 hospital districts have achieved approximately the same level of survival.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20862662     DOI: 10.1002/sim.4046

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Avoidable deaths and random variation in patients' survival.

Authors:  K Seppä; T Hakulinen; E Läärä
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

2.  The Mortality-to-Incidence Ratio Is Not a Valid Proxy for Cancer Survival.

Authors:  Libby Ellis; Aurélien Belot; Bernard Rachet; Michel P Coleman
Journal:  J Glob Oncol       Date:  2019-05

3.  No 'cure' within 12 years of diagnosis among breast cancer patients who are diagnosed via mammographic screening: women diagnosed in the West Midlands region of England 1989-2011.

Authors:  L M Woods; M Morris; B Rachet
Journal:  Ann Oncol       Date:  2016-08-29       Impact factor: 32.976

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.